Trilogy Capital’s Opko Health OPK Stock Holding History

Trilogy Capital’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-227	Closed	-$1K	–	437
2018 Q3	$1K	Buy	+227	New	+$1.21K	﹤0.01%	576

Other funds holding OPK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Trilogy Capital's OPK Position: Q4 2018 in Review

Trilogy Capital sold out of Opko Health (OPK) in Q4 2018, closing a stake of 227 shares — an estimated $1K sold.

Trilogy Capital first reported a position in OPK in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 202 funds tracked by Wall St. Rank hold OPK as of Q4 2018.

Trilogy Capital reported no remaining Opko Health position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 227 Opko Health shares in Q4 2018, an estimated $1K.
Trilogy Capital first reported a position in Opko Health in Q3 2018 and held it in 1 quarter.
Trilogy Capital's Opko Health position peaked at $1K in Q3 2018.
202 funds tracked by Wall St. Rank held Opko Health as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.